Tracking retinal nerve fiber layer loss after optic neuritis: A prospective study using optical coherence tomography

Multiple Sclerosis

Volumn 14, Issue 7, 2008, Pages 893-905

  Costello, Fiona ^a,e   Hodge, W ^b   Pan, Y I ^b   Eggenberger, E ^c   Coupland, S ^b   Kardon, R H ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

^c East Lansing   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e Rockyview Hospital   (Canada)

Author keywords

Multiple sclerosis; Optic neuritis; Optical imaging; Retinal nerve fiber layer

Indexed keywords

ADULT; ARTICLE; CASE STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE DURATION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE LESION; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; FOLLOW UP; METHODOLOGY; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBER; OPTIC NERVE; PATHOLOGY; RECURRENT DISEASE; VISION TEST;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS; OPTIC NERVE; OPTIC NEURITIS; PROSPECTIVE STUDIES; RECURRENCE; TOMOGRAPHY, OPTICAL COHERENCE; VISION TESTS; VISUAL ACUITY;

EID: 54449096858     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508091367     Document Type: Article

References (22)

1. Hickman SJ Dalton CM Miller DH Plant GT. Management of acute optic neuritis. Lancet 2002; 360: 1953-1962.
2. Miller D Barkhof F Montalban X Thompson A Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: Natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005; 4: 281-288.
3. Elbol P Work K. Retinal nerve fiber layer in multiple sclerosis. Acta Ophthalmol 1990; 68: 481-486.
4. Kerrison JB Flynn T Green WR. Retinal pathologic changes in multiple sclerosis. Retina 1994; 14: 445-451.
5. Frisen LF Hoyt WF. Insidious atrophy of retinal nerve fibers in multiple sclerosis. Arch Ophthalmol 1974; 92: 91-97.
6. Huang D Swanson EA Lin CP. Optical coherence tomography. Science 1991; 254: 1178-1181.
7. Baumal CR. Clinical applications of optical coherence tomography. Curr Opin Ophthalmol 1999; 10: 182-188.
8. Paunescu LA Schuman JS Price LL. Reproducibility of nerve fiber thickness, macular thickness and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci 2004; 45: 1716-1724.
9. Schuman JS Hee MR Puliafito CA. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography a pilot study. Arch Ophthalmol 1995; 113: 586-596.
10. Parisi V Manni G Spadaro M. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999; 40: 2520-2527.
11. Trip SA Schlottmann PG Jones SJ. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005; 58: 383-391.
12. Fisher JB Jacobs DA Markowitz CE. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113: 324-332.
13. Noval S Contreras I Rebolleda G Munoz-Negrete FJ. Optical coherence tomography versus automated perimetry for follow-up of optic neuritis. Acta Ophthalmol Scand 2006; 84: 790-794.
14. Costello F Coupland S Hodge W. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006; 59: 963-969.
15. Trip SA Schlottmann PG Jones SJ. Optic nerve atrophy and retinal nerve fiber layer thinning following optic neuritis: Evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 2006; 31: 286-293.
16. Sepulcre J Fernandez MM Salinas-Alaman A Garcia-Layana A Bejarano B Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007; 68: 1488-1494.
17. Gordon-Lipkin E Chodkowski B Reich DS. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007; 69: 1603-1609.
18. Trip SA Schlottmann PG Jones SJ. Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis. Mult Scler 2007; 13: 875-879.
19. Jacobs LD Beck RW Simon JH.; for the CHAMPS Study Group. Intramuscular beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000; 343: 898-904.
20. Poser CM Paty DW Sheinberg L. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
21. Ferris FL Kassoff A Bresnick GH. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94: 91-96.
22. Optic Neuritis Study Group. Visual function 5.years after optic neuritis. Arch Ophthalmol 1997; 115: 1545-1552.